Bedford Metals Deploys Field Crew to Ubiquity Lake Uranium Project 6-08-2024, 13:00

Buy-backs of shares in CoinShares International Limited 3-02-2023, 15:08

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00